Seven Lipoprotein Lipase Gene Polymorphisms, Lipid Fractions, and Coronary Disease: A HuGE Association Review and Meta-Analysis
The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Abstract
Lipoprotein lipase (LPL) is a key enzyme in lipoprotein metabolism and a major candidate gene for coronary heart disease (CHD). The authors assessed associations between 7 LPL polymorphisms and lipid fractions and CHD risk in population-based cohort, case-control, and cross-sectional studies published by January 2007. Meta-analyses of 22,734 CHD cases and 50,177 controls in 89 association studies focused on the relations of the T-93G (rs1800590), D9N (rs1801177), G188E, N291S (rs268), PvuII (rs285), HindIII (rs320), and S447X (rs328) polymorphisms to high density lipoprotein cholesterol, triglycerides, myocardial infarction, or coronary stenosis. Carriers of 9N or 291S had modestly adverse lipid profiles. Carriers of the less common allele of HindIII or of 447X had modestly advantageous profiles. The combined odds ratio for CHD among carriers was 1.33 (95% confidence interval (CI): 1.14, 1.56) for 9N, 1.07 (95% CI: 0.96, 1.20) for 291S, 0.89 (95% CI: 0.81, 0.98) for the less common HindIII allele, and 0.84 (95% CI: 0.75, 0.94) for 447X. For T-93G (odds ratio (OR) = 1.22, 95% CI: 0.98, 1.52) and PvuII (OR = 0.96, 95% CI: 0.89, 1.04), there were null associations with lipid levels or CHD risk; information on G188E was limited (OR = 2.80, 95% CI: 0.88, 8.87). The study of LPL genotypes confirms the existence of close interrelations between high density lipoprotein cholesterol and triglyceride pathways. The influence of these genotypes on CHD risk warrants further investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has also consistently been associated with lower triglycerides levels and lower coronary artery disease risk42.”
From Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation (2024) · cites this paper as [42]
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“which describes the percentage of total variation in point estimates attributable to genuine variation rather than sampling error ( 41 ).”
BackgroundSelf-citationBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216 · cited 1×
“More recently, with the completion of projects such as the Human Genome Project (18, 19) and the International HapMap Project (20, 21), genome-wide association studies have used assumption-free approaches to investigate loci with as-yet-unknown biologic relevance (22–28).”
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955 · cited 1×
“Funnel plots and associated statistical tests (42, 43) were used to assess assumptions involved in metaanalysis and to explore the relation between precision and magnitude of association.”
MethodThe sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882 · cited 1×
“, studies of haplotypes or investigation of any joint effects of gene-gene or genelipid factors), direct assessment in these populations of the impact of changes in lipid concentrations on CHD risk, or ‘‘Mendelian randomization’’ analyses (142).”
BackgroundA haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
A second generation human haplotype map of over 3.1 million SNPs
The International HapMap Consortium (2007) · Nature · doi:10.1038/nature06258 · Cited by 4,438 · cited 1×
“More recently, with the completion of projects such as the Human Genome Project (18, 19) and the International HapMap Project (20, 21), genome-wide association studies have used assumption-free approaches to investigate loci with as-yet-unknown biologic relevance (22–28).”
BackgroundRosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
The Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
International Journal of Obesity
(2019) · International Journal of Obesity · doi:10.1038/41366.1476-5497 · Cited by 2,078
Genomewide Association Analysis of Coronary Artery Disease
Samani, N. J., Erdmann, J., Hall, A. S., Hengstenberg, C., Mangino, M., Mayer, B., Dixon, R. J., Meitinger, T., Braund, P., Wichmann, H.-E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072366 · Cited by 2,044 · cited 1×
“3, has been replicated consistently (22, 23, 25, 27).”
BackgroundA Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., et al. (2007) · Science · doi:10.1126/science.1142842 · Cited by 1,594
A Common Allele on Chromosome 9 Associated with Coronary Heart Disease
McPherson, R., Pertsemlidis, A., Kavaslar, N., Stewart, A., Roberts, R., Cox, D. R., Hinds, D. A., Pennacchio, L. A., Tybjaerg-Hansen, A., Folsom, A. R., et al. (2007) · Science · doi:10.1126/science.1142447 · Cited by 1,587 · cited 1×
“3, has been replicated consistently (22, 23, 25, 27).”
BackgroundSarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408 · cited 1×
“Nonetheless, previous prospective studies of HDL cholesterol and triglycerides suggest that even the modest changes observed in these lipid concentrations related to LPL variants should be associated with an approximately 10% change in the risk of CHD, if the lipid markers have causal effects (143).”
Self-citationProblems of reporting genetic associations with complex outcomes
Colhoun, H. M., McKeigue, P. M., & Smith, G. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12715-8 · Cited by 1,204
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis
Goldberg, I. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37569-6 · Cited by 1,010
Ozaki, K., Ohnishi, Y., Iida, A., Sekine, A., Yamada, R., Tsunoda, T., Sato, H., Sato, H., Hori, M., Nakamura, Y., et al. (2002) · Nature Genetics · doi:10.1038/ng1047 · Cited by 952
Coronary heart disease statistics.
Allender, S. E., Peto, V., Scarborough, P., Kaur, A., & Rayner, M. (2008) · Deakin Research Online (Deakin University) · Cited by 928
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927 · cited 1×
“The modestly adverse lipid profile in carriers of 9N or 291S is consistent with reduced enzyme activity owing to amino acid substitutions in the N-terminal domain of LPL (see Web Figure 1), the part of the enzyme that is important for catalytic function (147).”
BackgroundAssociation of apolipoprotein E genotypes with lipid levels and coronary risk
Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., Dahlin, A., Ahlbom, A., Keavney, B., Collins, R., Wiman, B., de Faire, U., et al. (2007) · JAMA · doi:10.1001/jama.298.11.1300 · Cited by 794 · cited 1×
“For example, apolipoprotein E genotypes have been shown to be linearly associated with concentrations of low density lipoprotein cholesterol and CHD risk (17).”
Self-citationAbolishment of Alimentary Lipemia Following Injection of Heparin
Hahn, P. F. (1943) · Science · doi:10.1126/science.98.2531.19 · Cited by 605 · cited 1×
“Lipoprotein lipase (LPL), an enzyme discovered in 1943 (1), plays a central role in lipid metabolism by hydrolyzing”
BackgroundThe Canadian Journal of Cardiology.
Taylor, J. H. (2012) · PubMed · Cited by 590
Genetic associations in large versus small studies: an empirical assessment
Ioannidis, J. P., Trikalinos, T. A., Ntzani, E. E., & Contopoulos-Ioannidis, D. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12516-0 · Cited by 579
Assessment of cumulative evidence on genetic associations: interim guidelines
Ioannidis, J. P., Boffetta, P., Little, J., O'Brien, T. R., Uitterlinden, A. G., Vineis, P., Balding, D. J., Chokkalingam, A., Dolan, S. M., Flanders, W. D., et al. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym159 · Cited by 552 · cited 1×
“Proposed guidelines for assessing the strength of evidence from gene-disease association studies (141) would designate the findings as showing ‘‘moderate’’ evidence for S447X, D9N, and HindIII and ‘‘weak’’ evidence for the other 4 variants (Web Table 5 (http://aje.”
BackgroundSelf-citationBeisiegel, U., Weber, W., & Bengtsson-Olivecrona, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8342 · Cited by 468 · cited 1×
“proteins (4) with its ability to bind simultaneously to both”
BackgroundSchunkert, H., Götz, A., Braund, P., McGinnis, R., Tregouet, D.-A., Mangino, M., Linsel-Nitschke, P., Cambien, F., Hengstenberg, C., Stark, K., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.730614 · Cited by 387
Keavney, B., McKenzie, C., Parish, S., Palmer, A., Clark, S., Youngman, L., Delépine, M., Lathrop, M., Peto, R., & Collins, R. (2000) · The Lancet · doi:10.1016/s0140-6736(00)82009-7 · Cited by 345
Wittrup, H. H., Tybjærg-Hansen, A., & Nordestgaard, B. G. (1999) · Circulation · doi:10.1161/01.cir.99.22.2901 · Cited by 344
A Comparison of Tests for Hardy-Weinberg Equilibrium
Emigh, T. H. (1980) · Biometrics · doi:10.2307/2556115 · Cited by 245 · cited 2×
“03 as an indication of serious departure from Hardy-Weinberg equilibrium (38, 39).”
BackgroundMethodTriglyceride lpases and atherosclerosis
Olivecrona, G., & Olivecrona, T. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199510000-00009 · Cited by 238
Affected-sib-pair interval mapping and exclusion for complex genetic traits: Sampling considerations
Hauser, E. R., Boehnke, M., Guo, S.-W., & Risch, N. (1996) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(1996)13:2<117::aid-gepi1>3.0.co;2-5 · Cited by 213
Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes
Larson, M. G., Atwood, L. D., Benjamin, E. J., Cupples, L. A., D'Agostino, R. B., Fox, C. S., Govindaraju, D. R., Guo, C.-Y., Heard-Costa, N. L., Hwang, S.-J., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s5 · Cited by 190
The choice of a genetic model in the meta-analysis of molecular association studies
Minelli, C., Thompson, J. R., Abrams, K. R., Thakkinstian, A., & Attia, J. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi169 · Cited by 190 · cited 1×
“We conducted sensitivity analyses by repeating the meta-analyses assuming recessive, codominant, and unspecified (44) inheritance models and by performing fixed-effect meta-analyses.”
MethodMolecular pathobiology of the human lipoprotein lipase gene
Murthy, V., Julien, P., & Gagné, C. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00005-8 · Cited by 179 · cited 2×
“The majority of these mutations are rare, although they can appear at a relatively high prevalence in specific subpopulations (7).”
BackgroundIdentification of Four Gene Variants Associated with Myocardial Infarction
Shiffman, D., Ellis, S. G., Rowland, C. M., Malloy, M. J., Luke, M. M., Iakoubova, O. A., Pullinger, C. R., Cassano, J., Aouizerat, B. E., Fenwick, R. G., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/491674 · Cited by 160
Fisher, R. M., Humphries, S. E., & Talmud, P. J. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00199-8 · Cited by 158 · cited 1×
“It contains 10 exons and encodes a 448-amino acid mature protein (5).”
BackgroundJemaa, R., Fumeron, F., Poirier, O., Lecerf, L., Evans, A., Arveiler, D., Luc, G., Cambou, J. P., Bard, J. M., & Fruchart, J. C. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39198-7 · Cited by 152
Reuterwall, C., Hallqvist, J., Ahlbom, A., De Faire, U., Diderichsen, F., Hogstedt, C., Pershagen, G., Theorell, T., Wiman, B., Wolk, A., et al. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00554.x · Cited by 148
Self-citationGenotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study
Tobin, M. D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.11.014 · Cited by 143
Peacock, R. E., Hamsten, A., Nilsson‐Ehle, P., & Humphries, S. E. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90130-9 · Cited by 143
Mattu, R. K., Needham, E. W., Morgan, R., Rees, A., Hackshaw, A. K., Stocks, J., Elwood, P. C., & Galton, D. J. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1090 · Cited by 140
Chamberlain, J., Thorn, J. A., Oka, K., Galton, D. J., & Stocks, J. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90037-3 · Cited by 126
Jukema, J. W., van Boven, A. J., Groenemeijer, B., Zwinderman, A. H., Reiber, J. H. C., Bruschke, A. V. G., Henneman, J. A., Molhoek, G. P., Bruin, T., Jansen, H., et al. (1996) · Circulation · doi:10.1161/01.cir.94.8.1913 · Cited by 123
Self-citationGagné, S., Larson, M., Pimstone, S., Schaefer, E., Kastelein, J., Wilson, P., Ordovas, J., & Hayden, M. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.550609.x · Cited by 120
Self-citationNutrition, metabolism, and cardiovascular diseases : NMCD.
ScienceDirect (1991) · Cited by 116
Wittrup, H. H., Tybjaerg-Hansen, A., Abildgaard, S., Steffensen, R., Schnohr, P., & Nordestgaard, B. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119323 · Cited by 114
Langlois, S., Deeb, S., Brunzell, J. D., Kastelein, J. J., & Hayden, M. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.948 · Cited by 110 · cited 1×
“Since the identification of the first mutations in the LPL gene (6), more than 100 mutations have been identified (reviewed in detail by Murthy et al.”
BackgroundSelf-citationGerdes, C., Fisher, R. M., Nicaud, V., Boer, J., Humphries, S. E., Talmud, P. J., & Faergeman, O. (1997) · Circulation · doi:10.1161/01.cir.96.3.733 · Cited by 103
Stocks, J., Thorn, J., & Galton, D. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41510-x · Cited by 100
Shimo-Nakanishi, Y., Urabe, T., Hattori, N., Watanabe, Y., Nagao, T., Yokochi, M., Hamamoto, M., & Mizuno, Y. (2001) · Stroke · doi:10.1161/01.str.32.7.1481 · Cited by 99
Serum Lipid Survey and Its Recent Trend in the General Japanese Population in 2000
Arai, H., Yamamoto, A., Matsuzawa, Y., Saito, Y., Yamada, N., Oikawa, S., Mabuchi, H., Teramoto, T., Sasaki, J., Nakaya, N., et al. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.98 · Cited by 94
Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis
Thorn, J. A., Chamberlain, J., Alcolado, J. C., Oka, K., Chan, L., Stocks, J., & Galton, D. J. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90182-i · Cited by 90
A Bayesian Characterization of Hardy-Weinberg Disequilibrium
Shoemaker, J. S., Painter, I. S., & Weir, B. S. (1998) · Genetics · doi:10.1093/genetics/149.4.2079 · Cited by 89
Wang, X. L., McCredie, R. M., & Wilcken, D. E. L. (1996) · Circulation · doi:10.1161/01.cir.93.7.1339 · Cited by 84
Functional variants in the lipoprotein lipase gene and risk of cardiovascular disease
Hokanson, J. E. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199910000-00003 · Cited by 83
Fisher, R. M., Mailly, F., Peacock, R. E., Hamsten, A., Seed, M., Yudkin, J. S., Beisiegel, U., Feussner, G., Miller, G., & Humphries, S. E. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39195-1 · Cited by 81
Hokanson, J. E. (1997) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02827239 · Cited by 80 · cited 5×
“analyses used fixed-effect models (30) or unclear models (33), whereas our analysis uses random-effects models.”
BackgroundMethodResultInfluentialBOCKXMEER, F. M. V., Liu, Q., Mamotte, C., Burke, V., & Taylor, R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00717-6 · Cited by 77
Corella, D., Guillén, M., Portoles, O. D., Sorlí, J. V., Alonso, V., Folch, J., & Sáiz, C. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00894.x · Cited by 75
Jemaa, R., Tuzet, S., Portos, C., Betoulle, D., Apfelbaum, M., & Fumeron, F. (1995) · PubMed · Cited by 70
Baroni, M. G., Berni, A., Romeo, S., Arca, M., Tesorio, T., Sorropago, G., Mario, U. D., & Galton, D. J. (2003) · BMC Medical Genetics · doi:10.1186/1471-2350-4-8 · Cited by 69
Nettleton, J. A., Steffen, L. M., Ballantyne, C. M., Boerwinkle, E., & Folsom, A. R. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.025 · Cited by 69
Gerdes, C., Gerdes, L. U., HANSEN, P. S., & Færgeman, O. (1995) · Circulation · doi:10.1161/01.cir.92.7.1765 · Cited by 67
Yang, W. S., Nevin, D. N., Iwasaki, L., Peng, R., Brown, B. G., Brunzell, J. D., & Deeb, S. S. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37466-6 · Cited by 66
Schneider, J. G., Kreuzer, J., Hamann, A., Nawroth, P. P., & Dugi, K. A. (2002) · Diabetes · doi:10.2337/diabetes.51.3.867 · Cited by 62
Keavney, B. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh275 · Cited by 62 · cited 1×
“(117) (N291S); for studies of HDL cholesterol: Zhang et al.”
BackgroundSelf-citationGoodarzi, M. O., Guo, X., Taylor, K. D., Quiñones, M. J., Samayoa, C. G., Yang, H., Saad, M. F., Palotie, A. V., Krauss, R. M., Hsueh, W. A., et al. (2003) · Genetics in Medicine · doi:10.1097/01.gim.0000076971.55421.ad · Cited by 58
Peacock, R. E., Temple, A., Gudnason, V., Rosseneu, M., & Humphries, S. E. (1997) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(1997)14:3<265::aid-gepi5>3.0.co;2-4 · Cited by 58
Hu, Y., Liu, W., Huang, R., & Zhang, X. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600108-jlr200 · Cited by 57
Association of lipoprotein lipase gene polymorphisms with coronary artery disease
Anderson, J. L., King, G. J., Bair, T. L., Elmer, S. P., Muhlestein, J. B., Habashi, J., Mixson, L. A., & Carlquist, J. F. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00677-9 · Cited by 56
Skoglund-Andersson, C., Ehrenborg, E., Fisher, R. M., Olivecrona, G., Hamsten, A., & Karpe, F. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00016-9 · Cited by 55
Proenza, A. M., Poissonnet, C., Özata, M., Özen, S., Güran, Ş., Palou, A., & Strosberg, A. D. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801091 · Cited by 53
The lipoprotein lipase S447X polymorphism and plasma lipids
Lee, J., Tan, C. S., Chia, K., Tan, C., Chew, S., Ordovás, J. M., & Tai, E. S. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400016-jlr200 · Cited by 52
Vohl, M.-C., Lamarche, B., Moorjani, S., Prud’homme, D., Nadeau, A., Bouchard, C., Lupien, P.-J., & Després, J.-P. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.714 · Cited by 52
Friedlander, Y., Leitersdorf, E., Vecsler, R., Funke, H., & Kark, J. D. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00474-8 · Cited by 49
Holmer, S. R., Hengstenberg, C., Mayer, B., Döring, A., Löwel, H., Engel, S., Hense, H. W., Wolf, M., Klein, G., Riegger, G. A., et al. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00131-0 · Cited by 48
Ukkola, O. H., Garenc, C., Përusse, L., Bergeron, J., Després, J., Rao, D. C., & Bouchard, C. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00413-0 · Cited by 48
Zhang, Q., Cavanna, J., Winkelman, B. R., Shine, B., Gross, W., Marz, W., & Galton, D. J. (1995) · Clinical Genetics · doi:10.1111/j.1399-0004.1995.tb04112.x · Cited by 47
Ethnic Variation and In Vivo Effects of the −93t→g Promoter Variant in the Lipoprotein Lipase Gene
Ehrenborg, E., Clee, S. M., Pimstone, S. N., Reymer, P. W. A., Benlian, P., Hoogendijk, C. F., Davis, H. J., Bissada, N., Miao, L., Gagné, S. E., et al. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2672 · Cited by 46
Self-citationLPL polymorphism predicts stroke risk in men
Morrison, A. C., Ballantyne, C. M., Bray, M. S., Chambless, L. E., Sharrett, A. R., & Boerwinkle, E. (2002) · Genetic Epidemiology · doi:10.1002/gepi.0191 · Cited by 45
Arai, Y., Hirose, N., Yamamura, K., Nakazawa, S., Shimizu, K.-I., Takayama, M., Ebihara, Y., Homma, S., Gondo, Y., Masui, Y., et al. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0407-6 · Cited by 43
A gene-gender interaction affecting plasma lipoproteins in a genetic isolate.
Hegele, R. A., Evans, A. J., Tu, L., Ip, G., Brunt, J. H., & Connelly, P. W. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.671 · Cited by 43
Ko, Y., Ko, Y., Wu, S.-M., Teng, M., Chen, F.-R., Hsu, T., Chiang, C.-W., & Lee, Y. (1997) · Human Genetics · doi:10.1007/s004390050511 · Cited by 41
Arai, H., Yamamoto, A., Matsuzawa, Y., Saitō, Y., Yamada, N., Oikawa, S., Mabuchi, H., Teramoto, T., Sasaki, J., Nakaya, N., et al. (2005) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12.240 · Cited by 41
Myllykangas, L., Polvikoski, T., Sulkava, R., Notkola, I.-L., Rastas, S., Verkkoniemi, A., Tienari, P. J., Niinistö, L., Hardy, J., Pérez-Tur, J., et al. (2001) · Annals of Medicine · doi:10.3109/07853890109002098 · Cited by 41
COMBINING SUMMARIES OF BINARY OUTCOMES WITH THOSE OF CONTINUOUS OUTCOMES IN A META-ANALYSIS
Whitehead, A., Bailey, A. J., & Elbourne, D. (1999) · Journal of Biopharmaceutical Statistics · doi:10.1081/bip-100100997 · Cited by 38 · cited 1×
“Where mean values and standard deviations were given for log triglyceride levels, we converted these to approximate means and standard deviations for crude levels, assuming a log-normal distribution (34).”
MethodMcGladdery, S. E. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00670-5 · Cited by 38
Mero, N., Suurinkeroinen, L., Syvänne, M., Knudsen, P., Yki‐Järvinen, H., & Taskinen, M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33412-x · Cited by 38
Hadjadj, S., Gallois, Y., Simard, G., Bouhanick, B., Passa, P., Grimaldi, A., Drouin, P., Tichet, J., & Marre, M. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.12.1971 · Cited by 37
Humphries, S. E., Talmud, P. J., Cox, C., Sutherland, W. H. F., & Mann, J. I. (1996) · QJM · doi:10.1093/qjmed/89.9.671 · Cited by 36
Wittrup, H. H., Andersen, R. V., Tybjærg-Hansen, A., Jensen, G. B., & Nordestgaard, B. G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1725 · Cited by 36 · cited 3×
“b Because studies such as the Copenhagen City Heart Study ( 37 ) contained multiple case groups that were combined in the overall analysis and because of the inclusion of studies with”
BackgroundMethodInfluentialTalmud, P. J., Hall, S., Holleran, S., Ramakrishnan, R., Ginsberg, H. N., & Humphries, S. E. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32543-8 · Cited by 36
Abu‐Amero, K. K., Wyngaard, C. A., Al-Boudari, O. M., Kambouris, M., & Dzimiri, N. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-0597-loaoll · Cited by 35
Sentí, M., Bosch, M., Aubó, C., Elosúa, R., Masià, R., & Marrugat, J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00355-x · Cited by 34
Nicklas, B. J., Ferrell, R. E., Rogus, E. M., Berman, D. M., Ryan, A. S., Dennis, K. E., & Goldberg, A. P. (2000) · Human Genetics · doi:10.1007/s004390000292 · Cited by 34
Mitchell, R. J., Earl, L., Bray, P., Fripp, Y. J., & Williams, J. W. (1994) · PubMed · Cited by 34
Régis-Bailly, A., Visvikis‐Siest, S., Steinmetz, J., Feldmann, L., Briançon, S., Danchin, N., Zannad, F. M., & Siest, G. (1996) · Clinical Genetics · doi:10.1111/j.1399-0004.1996.tb02385.x · Cited by 33
Family study of lipoprotein lipase gene polymorphisms and plasma triglyceride levels
Georges, J., Régis-Bailly, A., Salah, D., Rakotovao, R., Siest, G., Visvikis‐Siest, S., & Tiret, L. (1996) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(1996)13:2<179::aid-gepi4>3.0.co;2-3 · Cited by 33
Boer, J. M. A., Kuivenhoven, J. A., Feskens, E. J. M., Schouten, E. G., Havekes, L. M., Seidell, J. C., Kastelein, J. J. P., & Kromhout, D. (1999) · Clinical Genetics · doi:10.1034/j.1399-0004.1999.560212.x · Cited by 31
Self-citationLarson, I. A., Hoffmann, M. M., Ordovás, J. M., Schaefer, E. J., März, W., & Kreuzer, J. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.7.963 · Cited by 30
Nierman, M. C., Rip, J., Kuivenhoven, J. A., van Raalte, D. H., Hutten, B. A., Sakai, N., Kastelein, J. J. P., & Stroes, E. S. G. (2005) · Metabolism · doi:10.1016/j.metabol.2005.05.016 · Cited by 30
Self-citationSalanti, G., Higgins, J. P. T., Trikalinos, T. A., & Ioannidis, J. P. A. (2006) · Statistics in Medicine · doi:10.1002/sim.2575 · Cited by 29
Self-citationGenetic markers in coronary artery disease in a Russian population.
Степанов, В. А., Puzyrev, V. P., Karpov, R. S., & Kutmin, A. I. (1998) · PubMed · Cited by 28
Sawano, M., Watanabe, Y., Ohmura, H., Shimada, K., Daida, H., Mokuno, H., & Yamaguchi, H. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.310 · Cited by 28
İşbir, T., Yılmaz, H., Ağaçhan, B., & Karaali, Z. (2003) · Clinical Genetics · doi:10.1034/j.1399-0004.2003.00137.x · Cited by 27
Arca, M., Campagna, F., Montali, A., Barillà, F., Mangieri, E., Tanzilli, G., Seccareccia, F., Campa, P. P., Ricci, G., & Pannitteri, G. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580507.x · Cited by 27
Razzaghi, H., Day, B. W., McClure, R. J., & Kamboh, M. I. (2001) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(00)00096-6 · Cited by 25 · cited 1×
“, the Asn291Ser substitution) is located in a heparin-binding cluster and may therefore affect the interaction of LPL with the cell wall glycosaminoglycans, whereas the 9N variant (the Asp9Asn substitution) is situated near a glycosylation site that may influence overall catalytic activity and secretion (148).”
BackgroundNierman, M. C., Prinsen, B. H. C. M. T., Rip, J., Veldman, R. J., Kuivenhoven, J. A., Kastelein, J. J. P., der Velden, M. G. M. D. S., & Stroes, E. S. G. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000188506.79946.ce · Cited by 25
Self-citationHumphries, S. E., Berglund, L., Isasi, C. R., Otvos, J. D., Kaluski, D., Deckelbaum, R. J., Shea, S., & Talmud, P. J. (2002) · PubMed · Cited by 24
Yang, Y., Ruiz-Narváez, E., Niu, T., Xu, X., & Campos, H. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400202-jlr200 · Cited by 24
The lipoprotein lipase Ser447Ter mutation and risk of stroke in the Chinese
Zhao, S., Tong, Q., Xiao, Z.-J., Cheng, Y.-C., Zhou, H.-N., & Nie, S. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00016-0 · Cited by 23
Rašlová, K., Smolková, B., Vohnout, B., Gašparovič, J., & Frohlich, J. J. (2001) · Metabolism · doi:10.1053/meta.2001.19499 · Cited by 22
Sent�, M., Aub�, C., Elosúa, R., Sala, J., Tom�s, M., & Marrugat, J. (2000) · Genetic Epidemiology · doi:10.1002/(sici)1098-2272(200003)18:3<203::aid-gepi2>3.0.co;2-i · Cited by 22
Rios, D. L. S., Vargas, A. F., Ewald, G. M., Torres, M. R., Zago, A. J., Callegari-Jacques, S. M., & Hutz, M. H. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.207 · Cited by 19
Lipoprotein Lipase Gene Polymorphisms in Croatian Patients with Coronary Artery Disease
Ferenčak, G., Pašalić, D., Gršković, B., Cheng, S., Fijal, B. A., Šesto, M., Skodla, J., & Stavljenić-Rukavina, A. (2003) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2003.082 · Cited by 19
Lipoprotein Lipase Gene Polymorphism and Lipid Profile in Coronary Artery Disease
Duman, B. S., Türkoğlu, Ç., Akpınar, B., Güden, M., Vertii, A., Dak, E., Çağatay, P., Günay, D., & Buyukdevrim, A. S. (2004) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2004-128-869-llgpal · Cited by 18
Masana, L., FEBRER, G., Cavanna, J., Baroni, M. G., März, W., Hoffmann, M. M., Shine, B. S. F., & Galton, D. J. (2001) · Clinical Science · doi:10.1042/cs1000183 · Cited by 17
叶平, 裴兰, & 王士雯 (1996) · PubMed · Cited by 17
Moennig, G., Wiebusch, H., Enbergs, A., Dorszewski, A., Kerber, S., Schulte, H., Vielhauer, C., Haverkamp, W., Assmann, G., BREITHARDT, G. E., et al. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00330-5 · Cited by 16
Ye, P., Pei, L., & Wang, S. (1996) · PubMed · Cited by 16
Yin, R., Wang, Y., Chen, G., Lin, W., Dezhai, Y., & Pan, S. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.273 · Cited by 14
Xin, X., Srinivasan, S. R., Chen, W., Boerwinkle, E., & Berenson, G. S. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00280-4 · Cited by 13
Kay, A., März, W., Hoffmann, M. M., Zhang, Q., Masana, L., Cavanna, J., Baroni, M. G., Shine, B. S. F., & Galton, D. J. (2002) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(01)00003-4 · Cited by 13
Lipoprotein lipase gene mutations in coronary artery disease.
Minnich, A., Baloukas, J., Roederer, G. O., Lussier‐Cacan, S., Davignon, J., & Genest, J. J. (1998) · PubMed · Cited by 12
Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes
Nierman, M. C., Rip, J., Kuivenhoven, J. A., Sakai, N., Kastelein, J. J. P., der Velden, M. G. M. D. S., Stroes, E. S. G., & Prinsen, B. H. C. M. T. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.08.038 · Cited by 10
Self-citationMetabolism of chylomicron-like emulsions in carriers of the S447X lipoprotein lipase polymorphism
Almeida, K. A., Schreiber, R., Amâncio, R. F., Bydlowski, S. P., Debes-Bravo, A., Issa, J. S., Strunz, C. M. C., & Maranhão, R. C. (2003) · Clinica Chimica Acta · doi:10.1016/s0009-8981(03)00289-4 · Cited by 9
Wj, L., Sheu, W. H., Jeng, C. Y., Ms, Y., & Yt, C. (2000) · PubMed · Cited by 8
Ronald, C. W., Järvinen, P. A., Kontula, K., Aalto‐Setälä, K., Ehnholm, C., Tenkanen, H., & Taskinen, M. (1993) · Nutrition Metabolism and Cardiovascular Diseases · Cited by 5
Glišić, S., Stankovic, S., Djurić, T., Živković, M., Stanković, A., & Alavantić, D. (2003) · Jugoslovenska medicinska biohemija · doi:10.2298/jmh0303237g · Cited by 4 · cited 1×
“Investigators in 2 studies (108, 140) provided unpublished data.”
Background[Study on lipoprotein lipase gene Hind III polymorphism in Chinese type IIb hyperlipoproteinemia].
Zhang, R., Liu, Y., Lu-chuan, Y., Bai, H., & Liu, B. (2003) · PubMed · Cited by 4
Arai, T., Tsukada, T., Okubo, M., Murase, T., & Matsumoto, K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00264-6 · Cited by 3
1826 Genotyping of multilocus risk markers in patients with myocardial infarction
Miličić, D. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)94941-4 · Cited by 2
Faure-Delanef, L., Zouali, H., Cohen, D., Bereziat, G., & Benlian, P. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)88206-8 · Cited by 2
Feliciello, I., Capossela, S., Cantile, M., Barbato, A., Cappuccio, F. P., Strazzullo, P., & Chinali, G. (2004) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80006-1 · Cited by 2
W07-O-003 ABCA1 is regulated by a novel G-protein receptor within the AP-3 secretory route
Schmitz, G., Kaminski, W. E., Bared, G. M., Liebisch, G., Orsó, E., & Langmann, T. (2005) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(05)80101-1 · Cited by 1
W07-P-001 S447X Lipoprotein lipase polymorphism in patients with premature coronary artery disease
Almeida, K., Strunz, C. M. C., Issa, J. S., Mansur, A. D. P., & Maranhão, R. C. (2005) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(05)80102-3 · Cited by 1
Hoffmann, M. M., Wolfarth, B., Schlemmer, E., Wieland, H., Baumstark, M. W., & März, W. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)80045-8 · Cited by 1
Henriksen, F. L., Rohold, A., Krogh, L., Nissen, H., Petersen, N. E., Beck‐Nielsen, H., & Hørder, M. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)88221-4 · Cited by 1
Paludo, C. A. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)94938-4 · Cited by 1
Gaudet, D., Vohl, M., Julien, P., Tremblay, G., Perron, P., Gagné, C., Bergeron, J., & Després, J. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)88466-3 · Cited by 1
Eiríksdóttir, G., Bergmann, O., Bolla, M. K., Sigurðsson, G., & Gudnason, V. G. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)80548-6 · Cited by 1
Mustafina, O. E., Ei, S., Tuktarova, I. A., & Хуснутдинова, Э. К. (2001) · PubMed · Cited by 1
Polymorphism of the gene encoding lipoprotein lipase in thai primary hyperlipoproteinemias.
Tirawanchai, N., Dulyasukdi, B., Likidlilid, A., Pongrapeeporn, K.-U. S., Poldee, S., & Amornrattana, A. (2000) · PubMed · Cited by 1
Research works printed but not linked: 29
- 2003, European Heart Journal, 24, 347
- Ye, 1996, Chinese medical sciences journal = Chung-kuo i hs eh k'o hs eh tsa chih / Chinese Academy of Medical Sciences, 11, 157
- 2007, 115, e69
- 2001, MOLEKULYARNAYA BIOLOGIYA MOSCOW, 35, 787
- 2000, Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 83, S19
- Zhang, 2003, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 20, 539
- 1997, 134, 77
- 1997, 134, 25
- 1998, American journal of human genetics, 61, A209
- 1999, 144, 13
- 1999, Clinical chemistry and laboratory medicine : CCLM / FESCC, 37, S264
- Humphries, 2002, Nutrition, metabolism, and cardiovascular diseases : NMCD, 12, 163
- 2003, American journal of human genetics, 73, 369
- 2003, European Heart Journal, 24, 348
- 2005, Atherosclerosis. Supplements, 6, 26
- 1998, Diabetologia, 41, A107
- Mitchell, 1994, Human biology; an international record of research, 66, 383
- 1997, ACTA ACAD MED HUBEI, 18, 120
- 2001, Clinical chemistry and laboratory medicine : CCLM / FESCC, 39, S303
- 1997, 134, 22
- 1999, 144, 140
- 2003, Zhonghua xin xue guan bing za zhi [Chinese journal of cardiovascular diseases], 31, 96
- 2005, Journal of the American College of Cardiology, 45, 416A
- 2000, ZHONGHUA YI XUE ZA ZHI TAIPEI, 63, 563
- 2001, MOL BIOLOGIYA MOSCOW, 35, 401
- 1998, Zhonghua xin xue guan bing za zhi [Chinese journal of cardiovascular diseases], 26, 309
- 2004, Zhonghua xin xue guan bing za zhi [Chinese journal of cardiovascular diseases], 32, 522
- 1996, American journal of human genetics, 59, A189
- Stepanov, 1998, Human biology; an international record of research, 70, 47
Cited by
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
Dewey, F. E., Gusarova, V., Dunbar, R. L., O’Dushlaine, C., Schurmann, C., Gottesman, O., McCarthy, S., Van Hout, C. V., Bruse, S., Dansky, H. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612790 · Cited by 885
Meta‐analysis of skewed data: Combining results reported on log‐transformed or raw scales
Higgins, J. P. T., White, I. R., & Anzures‐Cabrera, J. (2008) · Statistics in Medicine · doi:10.1002/sim.3427 · Cited by 481
“(4) Mean and standard deviation of log-transformed measurements (z̄ and sz).”
BackgroundSelf-citationGenetic Variants Influencing Circulating Lipid Levels and Risk of Coronary Artery Disease
Waterworth, D. M., Ricketts, S. L., Song, K., Chen, L., Zhao, J. H., Ripatti, S., Aulchenko, Y. S., Zhang, W., Yuan, X., Lim, N., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.201020 · Cited by 405
Testicular Cancer Survivorship: Research Strategies and Recommendations
Travis, L. B., Beard, C., Allan, J. M., Dahl, A. A., Feldman, D. R., Oldenburg, J., Daugaard, G., Kelly, J. L., Dolan, M. E., Hannigan, R., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq216 · Cited by 294
“Similarly, panels of single-nucleotide polymorphisms that are associated with blood concentrations of low- or high-density lipoproteins (192) or polymorphisms in lipoprotein lipase (193) have been related to subsequent cardiovascular events in the general population and could be examined in testicular cancer survivors…”
BackgroundAhmad, Z., Banerjee, P., Hamon, S., Chan, K.-C., Bouzelmat, A., Sasiela, W. J., Pordy, R., Mellis, S., Dansky, H., Gipe, D. A., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.039107 · Cited by 246
Metadata
- Authors
- Sagoo, G. S., Tatt, I., Salanti, G., Butterworth, A. S., Sarwar, N., van Maarle, M., Jukema, J. W., Wiman, B., Kastelein, J. J. P., Bennet, A. M., de Faire, U., Danesh, J., & Higgins, J. P. T.
- Affiliations
- University of Cambridge (GB)
- University of Bristol (GB)
- ORCID
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-10-15
- Volume
- 168
- Issue
- 11
- Pages
- 1233-1246
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2003283414
- Cited by
- 132
- References
- 145
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 5 · 2018: 7 · 2017: 6 · 2016: 9 · 2015: 11 · 2014: 11 · 2013: 14 · 2012: 4
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Explore Bristol Research (submittedVersion)
- Funders
- National Institute for Health and Care Research
- British Heart Foundation (RG/08/014/24067)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- lipoprotein lipase, LPL gene polymorphism, coronary artery disease, coronary artery stenosis, myocardial infarction, HDL cholesterol, triglycerides, lipoprotein metabolism, genetic susceptibility, PvuII, HindIII
- MeSH terms
- Alleles, Coronary Disease, Genotype, United Kingdom, Humans, Lipids, Lipoprotein Lipase, Cholesterol, HDL, Myocardial Infarction, Polymorphism, Genetic, Triglycerides, Confidence Intervals, Odds Ratio, Coronary Stenosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.